Change in the fair value of contingent consideration liabilities
0
-64,330
3,117
2,066
Change in fair value of debt, net
0
-12,197
491
490
Change in fair value of warrants
-4,507
-31,116
17,297
-291
Gain on settlement of accounts payable
1,136
2,584
-
-
Intangible asset impairment charge
0
67,808
-
-
Non-cash goodwill impairment charge
-
-
0
0
Acquired in-process research and development from the orphai acquistion
59,000
-
-
-
Reclassification of cumulative translation adjustment to net income
-
-
477
-
Gain on orphai acquisition
1,305
-
-
-
Amortization of discount on available-for-sale investments
0
62
188
236
Change in deferred tax liabilities
-
-
4,963
-
Prepaid expenses and other current assets
-362
3,639
-2,743
374
Right of use assets, operating leases and operating lease liabilities
-423
-28
-24
-27
Other assets
8
-1,782
-4,811
486
Accounts payable
260
5,911
-1,154
1,631
Accrued expenses and other current liabilities
-7,934
-7,163
5,304
-604
Other liabilities
-688
701
742
-
Net cash used in operating activities
-18,887
-7,627
-10,481
-9,928
Purchase of investments
0
0
4,922
15,707
Proceeds from maturities of investments
0
12,000
12,997
14,000
Purchase of property and equipment
0
0
4
74
Net cash assumed in the orphai acquisition
-8,001
-
-
-
Net cash provided by investing activities
8,001
12,000
8,071
-1,781
Payment of contingent consideration
-
-
0
0
Proceeds from issuance of common stock upon exercise of stock options
0
0
37
0
Proceeds from issuance of common stock, common warrants, and pre-funded warrants pursuant to june 2025 private placement offering, net of issuance costs
0
-
0
0
Proceeds from issuance of series c preferred stock and financing warrants pursuant to may 2026 private placement offering, net of issuance costs
103,639
-
-
-
Issuance of common stock in connection with the atm offerings, net of issuance costs
5,350
14,988
1,997
1,376
Repayment of debt
0
5,545
-
-
Cash settlement of common warrants
56
-
-
-
Net cash provided by financing activities
108,933
9,443
2,034
1,376
Effect of exchange rate changes on cash
-229
-1,462
-267
-41
Net increase in cash and cash equivalents
97,818
12,354
-643
-10,374
Cash and cash equivalents at beginning of period
18,163
5,809
6,452
6,212
Cash and cash equivalents at end of period
115,981
18,163
5,809
6,452
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.